Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stell cell breakthrough thrown into doubt
Research which claimed to produe stem cells by dipping blood cells (above) into acid, has been called into question.
Research which claimed to produe stem cells by dipping blood cells (above) into acid, has been called into question.

Questions over validity of research are being investigated

Questions have been raised over the credibility of a supposedly revolutionary technique for stem cell production.

Earlier this year the RIKEN Centre for Development Biology published results in the journal Nature, reporting the fast, cheap and ethical production of stems cells by dipping blood cells in acid.

But teams that tried to replicate the reported technique failed, and an investigation found that there had been 'Inappropriate handling" of data.

A statement by RIKEN President’s Prof Ryoji Noyori, said: I would like, first and foremost, to express my deepest regrets that articles published in Nature by RIKEN scientists are bringing into question the credibility of the scientific community.

"The authors of research papers bear full responsibility for all the observations presented in their papers and for their own scientific conclusions resulting from these observations. In particular, authors have a duty to handle the results of their own experiments with utmost care and objectivity.

"The reproducibility and credibility of the STAP phenomenon must be rigorously validated, not only by RIKEN scientists, but also by others. I have instructed our people to cooperate fully with researchers at outside institutions in their efforts to replicate the STAP cell results.

"It is extremely regrettable that significant discrepancies have been found to have been generated in the process of preparing the Nature articles for publication.

"We are investigating these discrepancies, with the understanding that it may become necessary to demand the withdrawal of the articles.

"Should the investigative committee conclude that there was research misconduct, we will take strict disciplinary action as stipulated by our own regulations.

"Research ethics are taken very seriously at RIKEN, and we will be redoubling our efforts to provide guidance and instruction to our scientists to ensure that we live up to society’s expectations.

"A critical attitude is an essential part of scientific research. In our efforts to advance research in the field of regenerative medicine, including iPS cells, we will respond earnestly to any and all scientific and technical questions that arise along the way."

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.